Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
C$0.00
C$7.32
▼
C$46.00
C$668.44MN/A387,394 shs52,208 shs
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$14.72
C$15.65
C$7.59
▼
C$17.64
C$516.19M3.7224061,243 shs680 shs
BioSyent Inc. stock logo
RX
BioSyent
C$16.12
+0.2%		C$15.18
C$10.65
▼
C$16.25
C$182.30M1.1100368,335 shs2,463 shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$22.40
+1.3%		$20.56
$12.71
▼
$31.05
$8.40M0.9821,912 shs2,156 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
0.00%0.00%0.00%0.00%0.00%
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
+1.31%-13.92%-13.46%+16.00%+19.19%
BioSyent Inc. stock logo
RX
BioSyent
+0.63%+2.49%+10.14%+15.27%+34.00%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
-0.18%-2.73%+9.78%+3.41%+19.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
C$0.00
C$7.32
▼
C$46.00
C$668.44MN/A387,394 shs52,208 shs
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$14.72
C$15.65
C$7.59
▼
C$17.64
C$516.19M3.7224061,243 shs680 shs
BioSyent Inc. stock logo
RX
BioSyent
C$16.12
+0.2%		C$15.18
C$10.65
▼
C$16.25
C$182.30M1.1100368,335 shs2,463 shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$22.40
+1.3%		$20.56
$12.71
▼
$31.05
$8.40M0.9821,912 shs2,156 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
0.00%0.00%0.00%0.00%0.00%
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
+1.31%-13.92%-13.46%+16.00%+19.19%
BioSyent Inc. stock logo
RX
BioSyent
+0.63%+2.49%+10.14%+15.27%+34.00%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
-0.18%-2.73%+9.78%+3.41%+19.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
0.00
N/AN/AN/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
4.00
Strong BuyN/AN/A
BioSyent Inc. stock logo
RX
BioSyent
4.00
Strong BuyN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/AN/AN/AN/AN/AN/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$59.22M8.72C$1.26 per share11.66C$1.23 per share11.99
BioSyent Inc. stock logo
RX
BioSyent
C$55.67M3.27C$5.24 per share3.07C$4.02 per share4.01
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
-C$800.44K-C$0.12N/AN/AN/A-6.21%-13.34%8.88%N/A
BioSyent Inc. stock logo
RX
BioSyent
C$7.02MC$0.8518.88N/AN/A17.73%22.92%12.86%N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/AN/AN/AN/AN/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
N/A2.02%N/AN/AN/A
BioSyent Inc. stock logo
RX
BioSyent
C$0.211.30%N/A24.59%N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/AN/AN/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
N/A
5.85
10.17
BioSyent Inc. stock logo
RX
BioSyent
6.85
2.07
6.91
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
15.39%
BioSyent Inc. stock logo
RX
BioSyent
11.79%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
N/A
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
16.20%
BioSyent Inc. stock logo
RX
BioSyent
33.65%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CanniMed Therapeutics Inc. stock logo
CMED
CanniMed Therapeutics
147,00024.76 millionN/ANot Optionable
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
1035.07 millionN/ANot Optionable
BioSyent Inc. stock logo
RX
BioSyent
6011.31 millionN/ANot Optionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A375,000N/ANot Optionable

Recent News About These Companies

Cours Roundhill Cannabis ETF - USD
September 13, 2026  |  zonebourse.comZ
Roundhill Cannabis ETF (BATS:WEED) Short Interest Update
September 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016264
Roundhill Cannabis ETF (BATS:WEED) Shares Down 1.8% - Time to Sell?
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013835
Roundhill Cannabis ETF
August 18, 2026  |  markets.ft.comhttps://markets.ft.com/data/etfs/tearsheet/summary?s=WEED:BTQ:USD
Listed Funds Trust - Roundhill Cannabis ETF
June 24, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/weed-listed-funds-trust-roundhill-cannabis-etf
5 ETFs Up At Least 5% Last Week's Market Rout
June 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2935285/5-etfs-up-at-least-5-last-week-s-market-rout?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2935285
100 Days Into the Iran War: Winning & Losing ETF Areas
June 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2933607/100-days-into-the-iran-war-winning-losing-etf-areas?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2933607
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
May 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2921525/us-reclassifies-weed-can-cannabis-etfs-give-your-portfolio-a-new-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2921525
Sector ETFs rally in April despite inflation and growth concerns
May 5, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/sector-etfs-rally-in-april-despite-inflation-and-growth-concerns/gm-GMBF0D3441
Best-Performing ETFs of April
May 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2914473/best-performing-etfs-of-april?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2914473
Cannabis ETFs: Regulatory Momentum Returns Focus
April 30, 2026  |  etftrends.comE
ETF sectors rally on chip surge, cannabis gains, oil jump
April 29, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-on-chip-surge-cannabis-gains-oil-jump/gm-GM17BC3388
ETF sectors rally as healthcare CapEx growth accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-as-healthcare-capex-growth-accelerates/gm-GM8CDC252B
Semiconductors, cannabis ETFs lead gains as sector rotation accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/semiconductors-cannabis-etfs-lead-gains-as-sector-rotation-accelerates/gm-GM7C8E74D8
4 Best-Performing ETF Areas of Last Week
April 28, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2909237/4-best-performing-etf-areas-of-last-week?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2909237
How to buy marijuana stocks: A beginner’s guide
March 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/how-to-buy-marijuana-stocks-a-beginner-s-guide/ar-AA1V1gHo
Roundhill Cannabis ETF : WEED
March 24, 2026  |  247wallst.comhttps://247wallst.com/companies/weed/
Santa Rally Falls Short: Top ETF Performers of December
January 2, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2811211/santa-rally-falls-short-top-etf-performers-of-december?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2811211
Cannabis ETFs surge on Trump's reclassification review
December 18, 2025  |  msn.comhttps://www.msn.com/en-xl/news/other/cannabis-etfs-surge-on-trump-s-reclassification-review/ar-AA1SA2lM
Cannabis ETF (WEED) Hits a New 52-Week High
December 17, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2805373/cannabis-etf-weed-hits-a-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2805373

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Shoppers browse folded and hanging clothing in a retail apparel store with shelves and racks displayed.
3 Retail Stocks to Watch After a Big Consumer Earnings Week
By Dan Schmidt | August 29, 2026
Accelerant logo displayed over a digital background with server racks and glowing data network graphics.
Accelerant’s Take-Private Deal Raises a Bigger Question for Insurance Stocks
By Nathan Reiff | September 4, 2026
Marex logo displayed over a blurred trading floor with world map graphics and financial charts on multiple monitors.
Marex Stock Doubles on Record Profits, But Can the Rally Continue?
By Peter Frank | September 16, 2026
CanniMed Therapeutics stock logo

CanniMed Therapeutics TSE:CMED

CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada. As of March 28, 2018, CanniMed Therapeutics Inc. operates as a subsidiary of Aurora Cannabis Inc.

Fennec Pharmaceuticals stock logo

Fennec Pharmaceuticals TSE:FRX

C$14.72 0.00 (0.00%)
As of 09/16/2026 05:17 PM Eastern

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer patients. PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom ( U.K. ) approval in October 2023 under the brand name PEDMARQSI®. In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, with rights to commercialize PEDMARQSI® in Europe, U.K., Australia and New Zealand. PEDMARQSI is now commercially available in the U.K. and Germany. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection.

BioSyent stock logo

BioSyent CVE:RX

C$16.12 +0.04 (+0.25%)
As of 11:57 AM Eastern

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$22.40 +0.29 (+1.29%)
As of 01:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas